FDA Inspection 1292178 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1053485

The FDA completed an inspection of Octapharma Plasma, Inc. on November 6, 2025 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 6, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Charlotte, NC (United States)